Board Meeting27 May 2026, 09:21 pm
Rossari Biotech Re-appoints Esha Padmanabhan Achan as Director
AI Summary
Rossari Biotech Ltd has re-appointed Ms. Esha Padmanabhan Achan as a Non-Executive Independent Director for a second term of 3 years, commencing from October 21, 2026, to October 20, 2029, subject to members' approval. The board also approved the grant of 830050 stock options under the Rossari Employee Stock Option Plan – 2019.
Key Highlights
- Esha Padmanabhan Achan re-appointed as Non-Executive Independent Director.
- Re-appointment is for a second term of 3 years, effective October 21, 2026.
- Board approved grant of 830050 stock options under ESOP 2019.
- Achan satisfies criteria under Companies Act, 2013 and Listing Regulations.
- Achan is not related to any other director and holds no shares in the company.
Price Impact
More from ROSSARI